Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000938
Chunk: 69

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 69
---
 by the Company of any notification with respect to the suspension of the registration
or qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction
in the United States or its receipt of written notice of the initiation or threatening of any proceeding for such purpose.

| 4 |

e. As
promptly as reasonably practicable after becoming aware of any event or fact, the result of which makes a material fact included in any
Registration Statement, as then in effect, or any prospectus included therein untrue or results in the omission of a material fact required
to be stated therein or necessary in order to make the statements then made therein (in the case of any prospectus, in light of the circumstances
under which they were made) not misleading, the Company shall notify the Investor in writing of the happening of such event or existence
of such facts and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission,
and deliver a copy of such supplement or amendment to the Investor. The Company shall also promptly notify the Investor in writing (i)
when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when any Registration Statement or any
post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Investor by email or facsimile
on the same day of such effectiveness or by overnight mail), (ii) of any request by the SEC for amendments or supplements to any Registration
Statement or related prospectus or related information, and (iii) of the Company’s reasonable determination that a post-effective
amendment to any Registration Statement would be appropriate.

f. The
Company shall use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of
any Registration Statement, or the suspension of the qualification of any Registrable Securities for sale in any jurisdiction and, if
such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify
the Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any
proceeding for such purpose.

g. The
Company shall (i) cause all the Registrable Securities to be listed on the Principal Market if the listing of such Registrable Securities
is then permitted under the rules of the Principal Market, or (ii) secure designation and quotation of all the Registrable Securities
on the Principal Market. The Company shall